×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

GS-III :
  • 02 June, 2020

  • 5 Min Read

Avifavir

Avifavir

  • Russia will start giving its first drug approved to treat COVID-19 to patients next week, its state financial backer said, a move it hopes will ease strains on the health system.
  • Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11.
  • Avifavir, known generically as favipiravir, was first developed in the late 1990s by a Japanese company later bought by Fujifilm as it moved into healthcare.
  • RDIF head Kirill Dmitriev said Russian scientists had modified the drug to enhance it, and said Moscow would be ready to share the details of those modifications within two weeks.
  • Japan has been trialling the same drug, known there as Avigan.
  • It has won plaudits from Prime Minister Shinzo Abe and $128 million in government funding, but has yet to be approved for use.

Source: TH


DNA

17 Sep,2021

Students Achievement

Search By Date

Newsletter Subscription
SMS Alerts